<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MSL Training with HeyGen Avatar - Dr. Alex</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Arial, sans-serif;
            margin: 0;
            padding: 20px;
            background: linear-gradient(135deg, #f0f4f8 0%, #e2e8f0 100%);
            min-height: 100vh;
        }
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            border-radius: 12px;
            padding: 30px;
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.1);
        }
        .header {
            text-align: center;
            margin-bottom: 30px;
        }
        .header h1 {
            color: #2563eb;
            font-size: 2.5rem;
            margin-bottom: 10px;
        }
        .header p {
            color: #64748b;
            font-size: 1.1rem;
        }
        .avatar-section {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
            border-radius: 12px;
            padding: 20px;
            margin-bottom: 30px;
            border: 2px solid #e2e8f0;
        }
        .avatar-section h2 {
            color: #1e293b;
            font-size: 1.5rem;
            margin-bottom: 15px;
            text-align: center;
        }
        .script-section {
            background: #f8fafc;
            border-radius: 8px;
            padding: 20px;
            margin-top: 20px;
            border-left: 4px solid #3b82f6;
        }
        .script-section h3 {
            color: #1e293b;
            margin-bottom: 15px;
        }
        .script-content {
            background: white;
            padding: 15px;
            border-radius: 6px;
            border: 1px solid #e2e8f0;
            font-size: 14px;
            line-height: 1.6;
        }
        .key-points {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 15px;
            margin-top: 15px;
        }
        .key-point {
            background: white;
            padding: 15px;
            border-radius: 6px;
            border: 1px solid #e2e8f0;
        }
        .key-point h4 {
            color: #2563eb;
            margin-top: 0;
            margin-bottom: 10px;
            font-size: 16px;
        }
        .key-point ul {
            margin: 0;
            padding-left: 20px;
        }
        .key-point li {
            margin-bottom: 5px;
            color: #475569;
            font-size: 13px;
        }
        .back-button {
            display: inline-block;
            margin-top: 20px;
            padding: 12px 24px;
            background: #3b82f6;
            color: white;
            text-decoration: none;
            border-radius: 6px;
            font-weight: 500;
            transition: background 0.2s;
        }
        .back-button:hover {
            background: #2563eb;
        }
        .instructions {
            background: #ecfdf5;
            border: 1px solid #bbf7d0;
            border-radius: 8px;
            padding: 20px;
            margin-bottom: 20px;
        }
        .instructions h3 {
            color: #166534;
            margin-top: 0;
        }
        .instructions p {
            color: #15803d;
            margin-bottom: 10px;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>ü©∫ MSL Training with Dr. Alex</h1>
            <p>Interactive HeyGen Avatar Demo - Tafamidis Discussion</p>
        </div>

        <div class="instructions">
            <h3>üìã How to Use This Demo</h3>
            <p><strong>1.</strong> The HeyGen avatar will appear as a small circle in the bottom-left corner</p>
            <p><strong>2.</strong> Click the avatar to expand it and start the conversation</p>
            <p><strong>3.</strong> Use the MSL script below as your guide for the discussion</p>
            <p><strong>4.</strong> Practice presenting the tafamidis dose comparison data to Dr. Alex</p>
        </div>

        <div class="avatar-section">
            <h2>ü§ñ Dr. Alex - Cardiologist HCP Avatar</h2>
            <p style="text-align: center; color: #64748b; margin-bottom: 20px;">
                The interactive avatar will initialize in the bottom-left corner of your screen.
                Click to expand and begin your MSL training session.
            </p>
            <div style="text-align: center; padding: 20px;">
                <div style="display: inline-block; padding: 20px; background: #e0f2fe; border-radius: 12px; border: 2px dashed #0284c7;">
                    <p style="color: #0284c7; font-weight: 600; margin: 0;">
                        üìç Avatar will appear here (bottom-left corner)
                    </p>
                </div>
            </div>
        </div>

        <div class="script-section">
            <h3>üìã MSL Reference Script - Tafamidis Discussion</h3>
            <div class="script-content">
                <p><strong>üíº Opening:</strong> "Hi Dr. Alex, thanks for making time today‚ÄîI'll keep it brief. I wanted to walk you through the latest insights comparing tafamidis 80 mg and 20 mg based on the long-term data."</p>
                
                <p><strong>üìä Study Overview:</strong> "The data comes from the ATTR-ACT trial and its long-term extension. Patients were randomized to tafamidis 80 mg, 20 mg, or placebo, followed for up to 51 months."</p>
                
                <p><strong>‚úÖ Wrap-up:</strong> "So overall, while both doses helped, the 80 mg dose showed more robust and earlier benefit across multiple endpoints‚Äîincluding mortality, function, and biomarkers."</p>
            </div>

            <div class="key-points">
                <div class="key-point">
                    <h4>‚ö∞Ô∏è Mortality Data</h4>
                    <ul>
                        <li>80mg: Statistically significant reduction</li>
                        <li>20mg: Trend, not significant</li>
                        <li>30% relative reduction (80mg vs 20mg)</li>
                    </ul>
                </div>
                
                <div class="key-point">
                    <h4>üßç Functional Outcomes</h4>
                    <ul>
                        <li>80mg effect: By Month 6</li>
                        <li>20mg effect: Closer to Month 12</li>
                        <li>Both doses better than placebo</li>
                    </ul>
                </div>
                
                <div class="key-point">
                    <h4>üß™ Biomarkers</h4>
                    <ul>
                        <li>Higher TTR stabilization with 80mg</li>
                        <li>Lower NT-proBNP increases (80mg)</li>
                        <li>Statistically significant for 80mg</li>
                    </ul>
                </div>
                
                <div class="key-point">
                    <h4>üíä Practical Considerations</h4>
                    <ul>
                        <li>All patients transitioned to 61mg (free acid)</li>
                        <li>Bioequivalent to 80mg meglumine</li>
                        <li>No dose-limiting safety issues</li>
                    </ul>
                </div>
            </div>
        </div>

        <a href="../" class="back-button">‚Üê Back to Main Application</a>
    </div>

    <!-- HeyGen Avatar Embed Script -->
    <script>
        !function(window) {
            const host = "https://labs.heygen.com";
            const url = host + "/guest/streaming-embed?share=eyJxdWFsaXR5IjoiaGlnaCIsImF2YXRhck5hbWUiOiJEZXh0ZXJfRG9jdG9yX1N0YW5kaW5nMl9w%0D%0AdWJsaWMiLCJwcmV2aWV3SW1nIjoiaHR0cHM6Ly9maWxlczIuaGV5Z2VuLmFpL2F2YXRhci92My84%0D%0AOGQ0MjFmOTM5MDQ0YmIwOGQ4OTJlODMzOTMxOTQ4Yl80NTU5MC9wcmV2aWV3X3RhbGtfMS53ZWJw%0D%0AIiwibmVlZFJlbW92ZUJhY2tncm91bmQiOmZhbHNlLCJrbm93bGVkZ2VCYXNlSWQiOiIyZmZkZGQ1%0D%0AMjhiYWE0MTFkOWNkY2Q5NzJiMzhkNTM1MCIsInVzZXJuYW1lIjoiNGE2MjIwYWQyNjUwNDFkNWI4%0D%0ANTk2NjZjMDNiY2FmZjcifQ%3D%3D&inIFrame=1";
            const clientWidth = document.body.clientWidth;
            const wrapDiv = document.createElement("div");
            wrapDiv.id = "heygen-streaming-embed";
            
            const container = document.createElement("div");
            container.id = "heygen-streaming-container";
            
            const stylesheet = document.createElement("style");
            stylesheet.innerHTML = `
                #heygen-streaming-embed {
                    z-index: 9999;
                    position: fixed;
                    left: 40px;
                    bottom: 40px;
                    width: 200px;
                    height: 200px;
                    border-radius: 50%;
                    border: 2px solid #fff;
                    box-shadow: 0px 8px 24px 0px rgba(0, 0, 0, 0.12);
                    transition: all linear 0.1s;
                    overflow: hidden;
                    opacity: 0;
                    visibility: hidden;
                }
                #heygen-streaming-embed.show {
                    opacity: 1;
                    visibility: visible;
                }
                #heygen-streaming-embed.expand {
                    ${clientWidth < 540 ? "height: 266px; width: 96%; left: 50%; transform: translateX(-50%);" : "height: 366px; width: calc(366px * 16 / 9);"}
                    border: 0;
                    border-radius: 8px;
                }
                #heygen-streaming-container {
                    width: 100%;
                    height: 100%;
                }
                #heygen-streaming-container iframe {
                    width: 100%;
                    height: 100%;
                    border: 0;
                }
            `;
            
            const iframe = document.createElement("iframe");
            iframe.allowFullscreen = false;
            iframe.title = "Dr. Alex - HeyGen Avatar";
            iframe.role = "dialog";
            iframe.allow = "microphone";
            iframe.src = url;
            
            let visible = false;
            let initial = false;
            
            window.addEventListener("message", (e) => {
                if (e.origin === host && e.data && e.data.type && "streaming-embed" === e.data.type) {
                    if ("init" === e.data.action) {
                        initial = true;
                        wrapDiv.classList.toggle("show", initial);
                    } else if ("show" === e.data.action) {
                        visible = true;
                        wrapDiv.classList.toggle("expand", visible);
                    } else if ("hide" === e.data.action) {
                        visible = false;
                        wrapDiv.classList.toggle("expand", visible);
                    }
                }
            });
            
            container.appendChild(iframe);
            wrapDiv.appendChild(stylesheet);
            wrapDiv.appendChild(container);
            document.body.appendChild(wrapDiv);
        }(globalThis);
    </script>
</body>
</html> 